Pet Pharm Biotech Co., Ltd. (TPEX:7762)
Taiwan · Delayed Price · Currency is TWD 50.70
-0.20 (-0.39%)
At close: Jun 18, 2026
Pet Pharm Biotech Market Cap
Pet Pharm Biotech has a market cap or net worth of 2.9 billion as of June 18, 2026. Its market cap has increased by 10.65% in one year.
Market Cap
2.90B
Enterprise Value
2.51B
Revenue
222.03M
Ranking
n/a
PE Ratio
110.22
Stock Price
50.70
Market Cap Chart
Since July 26, 2024, Pet Pharm Biotech's market cap has increased from 1.39B to 2.90B, an increase of 108.43%. That is a compound annual growth rate of 47.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 2.90B | -19.05% |
| Dec 31, 2025 | 3.58B | 116.51% |
| Dec 31, 2024 | 1.66B | 18.92% |
| Jul 26, 2024 | 1.39B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HanchorBio | 21.65B |
| Elixiron Immunotherapeutics (Cayman) Limited | 9.49B |
| Tripartite Therapeutics | 8.11B |
| Intelligene | 6.61B |
| Uwell Biopharma | 6.43B |
| Obigen Pharma | 3.89B |
| BIONET Therapeutics | 2.58B |
| FullHope Biomedical | 1.17B |